Evoke Pharma Stock Forecast - Accumulation Distribution
| EVOK Stock | USD 4.43 0.06 1.37% |
Evoke Stock Forecast is based on your current time horizon. Although Evoke Pharma's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Evoke Pharma's systematic risk associated with finding meaningful patterns of Evoke Pharma fundamentals over time.
Evoke |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 3409.5 | 1865.54 |
| Check Evoke Pharma Volatility | Backtest Evoke Pharma | Trend Details |
Evoke Pharma Trading Date Momentum
| On October 04 2024 Evoke Pharma was traded for 5.25 at the closing time. The top price for the day was 6.00 and the lowest listed price was 4.91 . The trading volume for the day was 218.6 K. The trading history from October 4, 2024 was a factor to the next trading day price upswing. The overall trading delta against the next closing price was 0.96% . The overall trading delta against the current closing price is 3.27% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Evoke Pharma to competition |
Other Forecasting Options for Evoke Pharma
For every potential investor in Evoke, whether a beginner or expert, Evoke Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Evoke Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Evoke. Basic forecasting techniques help filter out the noise by identifying Evoke Pharma's price trends.Evoke Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Evoke Pharma stock to make a market-neutral strategy. Peer analysis of Evoke Pharma could also be used in its relative valuation, which is a method of valuing Evoke Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Evoke Pharma Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Evoke Pharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Evoke Pharma's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Evoke Pharma Market Strength Events
Market strength indicators help investors to evaluate how Evoke Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Evoke Pharma shares will generate the highest return on investment. By undertsting and applying Evoke Pharma stock market strength indicators, traders can identify Evoke Pharma entry and exit signals to maximize returns.
Evoke Pharma Risk Indicators
The analysis of Evoke Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Evoke Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting evoke stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.85 | |||
| Semi Deviation | 4.66 | |||
| Standard Deviation | 6.22 | |||
| Variance | 38.74 | |||
| Downside Variance | 23.81 | |||
| Semi Variance | 21.72 | |||
| Expected Short fall | (4.48) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Evoke Pharma to cross-verify your projections. For more information on how to buy Evoke Stock please use our How to buy in Evoke Stock guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evoke Pharma. If investors know Evoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evoke Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.13) | Revenue Per Share 7.792 | Quarterly Revenue Growth 0.698 | Return On Assets (0.34) | Return On Equity (3.50) |
The market value of Evoke Pharma is measured differently than its book value, which is the value of Evoke that is recorded on the company's balance sheet. Investors also form their own opinion of Evoke Pharma's value that differs from its market value or its book value, called intrinsic value, which is Evoke Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evoke Pharma's market value can be influenced by many factors that don't directly affect Evoke Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evoke Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evoke Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evoke Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.